Advanced glycosylation end products in patients with diabetic nephropathy - PubMed (original) (raw)
. 1991 Sep 19;325(12):836-42.
doi: 10.1056/NEJM199109193251202.
Affiliations
- PMID: 1875967
- DOI: 10.1056/NEJM199109193251202
Free article
Advanced glycosylation end products in patients with diabetic nephropathy
Z Makita et al. N Engl J Med. 1991.
Free article
Abstract
Background: Glucose reacts nonenzymatically with proteins in vivo, chemically forming covalently attached glucose-addition products and cross-links between proteins. The excessive accumulation of rearranged late-glucose-addition products, or advanced glycosylation end products (AGEs), is believed to contribute to the chronic complications of diabetes mellitus.
Methods: To elucidate the relation of AGEs to diabetic complications, we used a radioreceptor assay to measure serum and tissue AGEs in diabetic (Types I and Type II) and nondiabetic patients with different levels of renal function. Serum AGEs were measured as a low-molecular-weight (less than or equal to 10 kd) peptide fraction and a high-molecular-weight (greater than 10 kd) protein fraction.
Results: The mean (+/- SD) AGE content of samples of arterial-wall collagen from 9 diabetic patients was significantly higher than that of samples from 18 nondiabetic patients (14.5 +/- 5.2 vs. 3.6 +/- 1.5 AGE units per milligram, P less than 0.001). Moreover, diabetic patients with end-stage renal disease had almost twice as much AGE in tissue as diabetic patients without renal disease (21.3 +/- 2.8 vs. 11.5 +/- 1.9 AGE units per milligram, P less than 0.001). The AGE levels in both serum fractions were elevated in the patients with diabetes, and the levels of AGE peptides correlated directly with serum creatinine (P less than 0.001) and inversely with creatinine clearance (P less than 0.005), suggesting that levels of AGE peptides increased with the severity of diabetic nephropathy. In six patients with diabetes who required hemodialysis, the levels of AGE peptides were five times higher than in eight normal subjects (82.8 +/- 9.4 vs. 15.6 +/- 3.4 AGE units per milliliter, P less than 0.001). In another group of diabetic patients the mean serum creatinine level, which decreased by 75 percent during a session of hemodialysis, whereas the level of AGE peptides decreased by only 24 percent. Serum levels of AGE peptides were normal in two patients with normal serum creatinine levels after renal transplantation.
Conclusions: AGEs accumulate at a faster-than-normal rate in arteries and the circulation of patients with diabetes; the increase in circulating AGE peptides parallels the severity of renal functional impairment in diabetic nephropathy.
Comment in
- Toward a basic understanding of diabetic complications.
Steffes MW, Mauer SM. Steffes MW, et al. N Engl J Med. 1991 Sep 19;325(12):883-4. doi: 10.1056/NEJM199109193251209. N Engl J Med. 1991. PMID: 1875974 No abstract available.
Similar articles
- The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T, Inoguchi T, Umeda F, Nawata H, Kawano K, Ochi H. Shimoike T, et al. Metabolism. 2000 Aug;49(8):1030-5. doi: 10.1053/meta.2000.7738. Metabolism. 2000. PMID: 10954022 - Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
Gerdemann A, Lemke HD, Nothdurft A, Heidland A, Münch G, Bahner U, Schinzel R. Gerdemann A, et al. Clin Nephrol. 2000 Oct;54(4):276-83. Clin Nephrol. 2000. PMID: 11076103 - A novel advanced glycation index and its association with diabetes and microangiopathy.
Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V. Sampathkumar R, et al. Metabolism. 2005 Aug;54(8):1002-7. doi: 10.1016/j.metabol.2005.02.017. Metabolism. 2005. PMID: 16092048 Clinical Trial. - Serum advanced glycosylation end products: a new class of uremic toxins?
Vlassara H. Vlassara H. Blood Purif. 1994;12(1):54-9. doi: 10.1159/000170145. Blood Purif. 1994. PMID: 7986476 Review. - Advanced glycation end products and the kidney.
Bohlender JM, Franke S, Stein G, Wolf G. Bohlender JM, et al. Am J Physiol Renal Physiol. 2005 Oct;289(4):F645-59. doi: 10.1152/ajprenal.00398.2004. Am J Physiol Renal Physiol. 2005. PMID: 16159899 Review.
Cited by
- A One-Month Advanced Glycation End Products-Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis.
Aroni A, Detopoulou P, Presvelos D, Kostopoulou E, Ioannidis A, Panoutsopoulos GI, Zyga S, Kosmidis G, Spiliotis BE, Rojas Gil AP. Aroni A, et al. Int J Mol Sci. 2024 Aug 15;25(16):8893. doi: 10.3390/ijms25168893. Int J Mol Sci. 2024. PMID: 39201577 Free PMC article. - An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition.
Uceda AB, Mariño L, Casasnovas R, Adrover M. Uceda AB, et al. Biophys Rev. 2024 Apr 12;16(2):189-218. doi: 10.1007/s12551-024-01188-4. eCollection 2024 Apr. Biophys Rev. 2024. PMID: 38737201 Free PMC article. Review. - Circular RNAs and the regulation of gene expression in diabetic nephropathy (Review).
Benitez MBM, Navarro YP, Azuara-Liceaga E, Cruz AT, Flores JV, Lopez-Canovas L. Benitez MBM, et al. Int J Mol Med. 2024 May;53(5):44. doi: 10.3892/ijmm.2024.5368. Epub 2024 Mar 22. Int J Mol Med. 2024. PMID: 38516776 Free PMC article. - Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study.
Kelly CB, Karanchi H, Yu JY, Leyva MJ, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Aston CE, Beisswenger PJ, Lyons TJ. Kelly CB, et al. J Diabetes Res. 2023 Aug 10;2023:8537693. doi: 10.1155/2023/8537693. eCollection 2023. J Diabetes Res. 2023. PMID: 37601831 Free PMC article. - Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer.
Senavirathna L, Pan S, Chen R. Senavirathna L, et al. Cancer Prev Res (Phila). 2023 Nov 1;16(11):601-610. doi: 10.1158/1940-6207.CAPR-23-0162. Cancer Prev Res (Phila). 2023. PMID: 37578815 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical